Caisse Des Depots Et Consignations’s Gilead Sciences GILD Stock Holding History

Caisse Des Depots Et Consignations’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$7.24M	Sell	57,303 -2,837	-5%	-$374K	0.12%	54
2026 Q1	$8.38M	Sell	60,140 -3,182	-5%	-$446K	0.14%	42
2025 Q4	$7.77M	Buy	63,322 +2,266	+4%	+$275K	0.18%	48
2025 Q3	$6.78M	Sell	61,056 -12,496	-17%	-$1.42M	0.29%	53
2025 Q2	$8.15M	Sell	73,552 -1,632	-2%	-$174K	0.34%	45
2025 Q1	$8.42M	Sell	75,184 -9,488	-11%	-$979K	0.41%	41
2024 Q4	$7.82M	Buy	+84,672	New	+$7.62M	0.38%	38

Other funds holding GILD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Caisse Des Depots Et Consignations's GILD Position: Q2 2026 in Review

Caisse Des Depots Et Consignations reduced its Gilead Sciences (GILD) stake by 4.7% in Q2 2026, selling an estimated $374K and leaving 57,303 shares worth $7.24M. The position accounts for 0.12% of the portfolio, ranked #54.

Caisse Des Depots Et Consignations first reported a position in GILD in Q4 2024 and has held it in 7 quarters since. The position peaked at $8.42M in Q1 2025. 2,278 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

Caisse Des Depots Et Consignations held 57,303 shares of Gilead Sciences worth $7.24M as of Q2 2026.
Caisse Des Depots Et Consignations sold 2,837 Gilead Sciences shares in Q2 2026, an estimated $374K.
Gilead Sciences made up 0.12% of Caisse Des Depots Et Consignations's portfolio in Q2 2026, its #54 holding.
Caisse Des Depots Et Consignations first reported a position in Gilead Sciences in Q4 2024 and has held it in 7 quarters since.
Caisse Des Depots Et Consignations's Gilead Sciences position peaked at $8.42M in Q1 2025.
2,278 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Caisse Des Depots Et Consignations's 13F filing for Q2 2026, filed 24 Jul 2026.